{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "marketState": "CLOSED", "regularMarketChangePercent": 3.999999, "regularMarketPrice": 3.0212, "exchange": "LSE", "shortName": "GERON CORP GERON ORD SHS", "longName": "Geron Corporation", "messageBoardId": "finmb_215864", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "regularMarketTime": 1683912479, "earningsTimestamp": 1683815400, "earningsTimestampStart": 1691578740, "earningsTimestampEnd": 1692014400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.359, "sharesOutstanding": 186348000, "bookValue": 0.205, "fiftyDayAverage": 2.512412, "fiftyDayAverageChange": 0.5087879, "fiftyDayAverageChangePercent": 0.20250972, "twoHundredDayAverage": 2.3564446, "twoHundredDayAverageChange": 0.66475534, "twoHundredDayAverageChangePercent": 0.28210098, "marketCap": 5212295, "priceToBook": 14.737561, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1517212800000, "priceHint": 4, "regularMarketChange": 0.11619997, "regularMarketDayHigh": 3.0212, "regularMarketDayRange": "2.935 - 3.0212", "regularMarketDayLow": 2.935, "regularMarketVolume": 3458, "regularMarketPreviousClose": 2.905, "bid": 0.0, "ask": 0.0, "fullExchangeName": "LSE", "financialCurrency": "USD", "regularMarketOpen": 2.985, "averageDailyVolume3Month": 4964, "averageDailyVolume10Day": 3841, "fiftyTwoWeekLowChange": 1.8161999, "fiftyTwoWeekLowChangePercent": 1.5072198, "fiftyTwoWeekRange": "1.205 - 4.11", "fiftyTwoWeekHighChange": -1.0888002, "fiftyTwoWeekHighChangePercent": -0.26491487, "fiftyTwoWeekLow": 1.205, "fiftyTwoWeekHigh": 4.11, "symbol": "0IV3.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "919 East Hillsdale Boulevard", "address2": "Suite 250", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 473 7700", "website": "https://www.geron.com", "industry": "", "sector": "", "longBusinessSummary": "Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.", "fullTimeEmployees": 107, "companyOfficers": [{"maxAge": 1, "name": "Dr. John A. Scarlett M.D.", "age": 71, "title": "Chairman, Pres & CEO", "yearBorn": 1951, "fiscalYear": 2022, "totalPay": {"raw": 1528462, "fmt": "1.53M", "longFmt": "1,528,462"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 4105147, "fmt": "4.11M", "longFmt": "4,105,147"}}, {"maxAge": 1, "name": "Ms. Olivia Kyusuk Bloom", "age": 53, "title": "Exec. VP of Fin., CFO & Treasurer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 826024, "fmt": "826.02k", "longFmt": "826,024"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1348190, "fmt": "1.35M", "longFmt": "1,348,190"}}, {"maxAge": 1, "name": "Dr. Andrew J. Grethlein", "age": 58, "title": "Exec. VP & COO", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 847199, "fmt": "847.2k", "longFmt": "847,199"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 995146, "fmt": "995.15k", "longFmt": "995,146"}}, {"maxAge": 1, "name": "Ms. Aron  Feingold", "title": "VP of Investor Relations & Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Stephen N. Rosenfield J.D.", "age": 72, "title": "Exec. VP, Chief Legal Officer & Corp. Sec.", "yearBorn": 1950, "fiscalYear": 2018, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Shannon  Odam", "title": "VP of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Melissa A. Kelly Behrs", "age": 58, "title": "Exec. VP of Bus. Operations & Chief Alliance Officer", "yearBorn": 1964, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Anil  Kapur", "age": 52, "title": "Exec. VP of Corp. Strategy & Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Edward E. Koval", "age": 60, "title": "Exec. VP & Chief Bus. Officer", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Faye  Feller M.D.", "age": 40, "title": "Exec. VP & Chief Medical Officer", "yearBorn": 1982, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 6, "shareHolderRightsRisk": 7, "overallRisk": 6, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}